- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03544424
A Study of Physical Activity paTTerns and Major Health Events in Older People With Implantable Cardiac Devices (PATTErn)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Manchester, United Kingdom, M13 9WL
- Manchester Heart Centre
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age 60+ years
- Functioning CIED in situ for at least 6 months
- Medtronic manufactured device compatible with CareLink® Cardiac Compass application (platform which measures and stores physiological parameters)
- Lives in the Greater Manchester area
- Able and willing to given written, informed consent to enter the study
Exclusion Criteria:
- Faulty or incompatible device
- Immobile (unable to walk in upright position)
- Active participant in a clinical trial which does not allow concurrent recruitment into this study
- People unable to consent in the English language (including the understanding of study literature which is published in English only)
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Study cohort
People over 60 years of age with a Medtronic CareLink® compatible CIED in situ recruited from the Manchester University NHS Foundation Trust, England, UK
|
No intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Non-elective Hospital Admissions
Time Frame: Retrospective: 12 months prior to enrolment (retrospective data spans 12 months prior to enrolment)
|
Non-elective hospital admissions, as defined as an emergency admission to an National Health Service (NHS) hospital within England or Wales for any reason. Data collected from NHS England. Number of Participants With Non-elective Hospital Admissions. |
Retrospective: 12 months prior to enrolment (retrospective data spans 12 months prior to enrolment)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Frailty
Time Frame: 30 days
|
Frailty as per Fried criteria Fried frailty criteria is a score between 1-5. A score of 0-1 = not frail A score of 2 = pre-frail A score of 3+ = frailty Reference: Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., ... & McBurnie, M. A. (2001). Frailty in older adults: evidence for a phenotype. The journals of gerontology series a: biological sciences and medical sciences, 56(3), M146-M157. |
30 days
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Adam Greenstein, MBChB, PhD, Manchester University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 215964
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.